TY - JOUR
T1 - RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes
AU - Deciphering Developmental Disorders Study
AU - Reijnders, Margot R.F.
AU - Ansor, Nurhuda M.
AU - Kousi, Maria
AU - Yue, Wyatt W.
AU - Tan, Perciliz L.
AU - Clarkson, Katie
AU - Clayton-Smith, Jill
AU - Corning, Ken
AU - Jones, Julie R.
AU - Lam, Wayne W.K.
AU - Mancini, Grazia M.S.
AU - Marcelis, Carlo
AU - Mohammed, Shehla
AU - Pfundt, Rolph
AU - Roifman, Maian
AU - Cohn, Ronald
AU - Chitayat, David
AU - Millard, Tom H.
AU - Katsanis, Elias Nicholas
AU - Brunner, Han G.
AU - Banka, Siddharth
N1 - Funding Information:
We would like to thank all the families for agreeing to participate in this study. We acknowledge the Rare Disease Foundation and the BC Children’s Hospital Foundation for their support for this work (S.B., grant number 17-48 ). N.K. is a Distinguished George W. Brumley Professor . W.W.Y. is a researcher at the Structural Genomics Consortium, a registered charity (number 1097737; funding details online). We thank Prof. Viki Allan (University of Manchester) for providing mammalian expression plasmids encoding GFP-Rac1, GFP-Rac1-T17N, and GFP-Rac1-Q61L. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003 ), a parallel funding partnership between the Wellcome Trust and the Department of Health , and the Wellcome Trust Sanger Institute (grant number WT098051 ). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83 granted by the Cambridge South REC and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research , through the Comprehensive Clinical Research Network.
Publisher Copyright:
© 2017 American Society of Human Genetics
PY - 2017/9/7
Y1 - 2017/9/7
N2 - RAC1 is a widely studied Rho GTPase, a class of molecules that modulate numerous cellular functions essential for normal development. RAC1 is highly conserved across species and is under strict mutational constraint. We report seven individuals with distinct de novo missense RAC1 mutations and varying degrees of developmental delay, brain malformations, and additional phenotypes. Four individuals, each harboring one of c.53G>A (p.Cys18Tyr), c.116A>G (p.Asn39Ser), c.218C>T (p.Pro73Leu), and c.470G>A (p.Cys157Tyr) variants, were microcephalic, with head circumferences between −2.5 to −5 SD. In contrast, two individuals with c.151G>A (p.Val51Met) and c.151G>C (p.Val51Leu) alleles were macrocephalic with head circumferences of +4.16 and +4.5 SD. One individual harboring a c.190T>G (p.Tyr64Asp) allele had head circumference in the normal range. Collectively, we observed an extraordinary spread of ∼10 SD of head circumferences orchestrated by distinct mutations in the same gene. In silico modeling, mouse fibroblasts spreading assays, and in vivo overexpression assays using zebrafish as a surrogate model demonstrated that the p.Cys18Tyr and p.Asn39Ser RAC1 variants function as dominant-negative alleles and result in microcephaly, reduced neuronal proliferation, and cerebellar abnormalities in vivo. Conversely, the p.Tyr64Asp substitution is constitutively active. The remaining mutations are probably weakly dominant negative or their effects are context dependent. These findings highlight the importance of RAC1 in neuronal development. Along with TRIO and HACE1, a sub-category of rare developmental disorders is emerging with RAC1 as the central player. We show that ultra-rare disorders caused by private, non-recurrent missense mutations that result in varying phenotypes are challenging to dissect, but can be delineated through focused international collaboration.
AB - RAC1 is a widely studied Rho GTPase, a class of molecules that modulate numerous cellular functions essential for normal development. RAC1 is highly conserved across species and is under strict mutational constraint. We report seven individuals with distinct de novo missense RAC1 mutations and varying degrees of developmental delay, brain malformations, and additional phenotypes. Four individuals, each harboring one of c.53G>A (p.Cys18Tyr), c.116A>G (p.Asn39Ser), c.218C>T (p.Pro73Leu), and c.470G>A (p.Cys157Tyr) variants, were microcephalic, with head circumferences between −2.5 to −5 SD. In contrast, two individuals with c.151G>A (p.Val51Met) and c.151G>C (p.Val51Leu) alleles were macrocephalic with head circumferences of +4.16 and +4.5 SD. One individual harboring a c.190T>G (p.Tyr64Asp) allele had head circumference in the normal range. Collectively, we observed an extraordinary spread of ∼10 SD of head circumferences orchestrated by distinct mutations in the same gene. In silico modeling, mouse fibroblasts spreading assays, and in vivo overexpression assays using zebrafish as a surrogate model demonstrated that the p.Cys18Tyr and p.Asn39Ser RAC1 variants function as dominant-negative alleles and result in microcephaly, reduced neuronal proliferation, and cerebellar abnormalities in vivo. Conversely, the p.Tyr64Asp substitution is constitutively active. The remaining mutations are probably weakly dominant negative or their effects are context dependent. These findings highlight the importance of RAC1 in neuronal development. Along with TRIO and HACE1, a sub-category of rare developmental disorders is emerging with RAC1 as the central player. We show that ultra-rare disorders caused by private, non-recurrent missense mutations that result in varying phenotypes are challenging to dissect, but can be delineated through focused international collaboration.
KW - HACE1
KW - RAC1
KW - Rho GTPase
KW - TRIO
KW - cerebellar abnormalities
KW - developmental disorders
KW - intellectual disability
KW - macrocephaly
KW - microcephaly
KW - neuronal proliferation
UR - http://www.scopus.com/inward/record.url?scp=85029537872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029537872&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2017.08.007
DO - 10.1016/j.ajhg.2017.08.007
M3 - Article
C2 - 28886345
AN - SCOPUS:85029537872
SN - 0002-9297
VL - 101
SP - 466
EP - 477
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -